EUVIMEDEUVIMED entdecken
Crossref

Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice

Wanling Lu, Lifang Xie, Yanhan Zhang, Hong Gao, David Geng, Chunguang Xie, Ming Liu, Gang Wang iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Wanling Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, People's Republic of …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose, Glycemic Control, Insulin. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Innovation Team and Talents Cultivation Program of National Administration of TCM, 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University, Key Project of Sichuan Provincial Administration of TCM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To achieve glucose‐activated transcriptional regulation of insulin analogue in skeletal muscle of T1D mice, thereby controlling blood glucose levels and preventing or mitigating diabetes‐related complications. Materials and Methods We developed the GANIT ( G lucose‐ A ctivated N FAT‐regulated I NSA‐F T ranscription) system, an innovative platform building upon the previously established intramuscular plasmid DNA (pDNA) delivery and expression system. In the GANIT system, skeletal muscle cells are genetically engineered to endogenously produce the insulin analogue INSA‐F ( Ins ulin A spart with F urin cleavage sites). The transcription of INSA‐F is precisely controlled by a glucose‐responsive promoter containing NFAT (Nuclear Factor of Activated T‐cells) regulatory motifs, which can be activated in response to changes in extracellular glucose concentrations. This design enables glucose‐dependent regulation of insulin analogue expression, mimicking physiological glucose‐responsive insulin secretion.

Results

T1D mice that received two GANIT treatments over a 2‐month experimental period demonstrated significant improvements in glucose homeostasis, glucose tolerance and glycated haemoglobin (HbA1c) levels. Additionally, the treatment effectively reduced oxidative stress and alleviated cardiac and renal fibrosis, while maintaining a favourable biosafety profile.

Conclusion

The GANIT system provides significant advantages in terms of efficiency, convenience and cost‐effectiveness, making it a promising approach for regulating blood glucose levels and alleviating diabetes‐related complications in insulin‐deficient diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Blood GlucoseGlycemic ControlInsulinInsulin AspartDiabetes Mellitus, ExperimentalAnimalsMiceMuscle, SkeletalNFATC Transcription FactorsGlucoseGlycated HemoglobinMaleHypoglycemic Agents

Stichwörter der Autor:innen

NFAToxidative stressplasmidrenal damageskeletal muscletranscriptional regulationtype 1 diabetes

Substanzen

Blood GlucoseInsulinNFATC Transcription FactorsInsulin AspartGlucoseGlycated HemoglobinHypoglycemic Agents

Autor:innen und Institutionen

  • National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, People's Republic of China.
  • Department of Anesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, People's Republic of China.
  • Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of TCM, Chengdu, Sichuan, People's Republic of China.
  • Trinity college, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medical Oncology/Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

ORCID-Profile: Gang Wang

Förderung

  • Innovation Team and Talents Cultivation Program of National Administration of TCM
  • 1.3.5 Project for Disciplines of Excellence, West China Hospital, Sichuan University
  • Key Project of Sichuan Provincial Administration of TCM
  • National Natural Science Foundation of China
  • Open Fund of Sichuan Provincial Key Laboratory for Traditional Chinese Medicine Regulation of Metabolic Diseases

Zitieren

APA

Lu, W., Xie, L., Zhang, Y., Gao, H., Geng, D., Xie, C., Liu, M., & Wang, G. (2025). Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16197

Vancouver

Lu W, Xie L, Zhang Y, Gao H, Geng D, Xie C, et al. Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16197

BibTeX
@article{Lu2025,
  author = {Lu, Wanling and Xie, Lifang and Zhang, Yanhan and Gao, Hong and Geng, David and Xie, Chunguang and Liu, Ming and Wang, Gang},
  title = {Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16197}
}
Kostenlos starten →